Risk of irAEs in patients with autoimmune diseases treated by immune checkpoint inhibitors for stage III or IV melanoma: results from a matched case–control study
暂无分享，去创建一个
J. Grob | C. Lebbé | O. Dereure | S. Dalle | P. Stoebner | L. Mortier | P. Saiag | S. Dalac | F. Aubin | C. Dutriaux | E. Maubec | T. Lesimple | C. Allayous | H. Montaudié | J. Arnault | F. Brunet-Possenti | F. Granel-Brocard | D. Legoupil | S. Trabelsi | J. de Quatrebarbes | L. Plaçais | B. Oriano | F. Granel‐Brocard | F. Brunet‐Possenti